lgbtDB

(Q33329)

Revision as of 02:30, 19 November 2024 by Superraptor (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Statements

title
Operative Complications, Vaginal Bleeding, and Practice Considerations for Patients on Testosterone Undergoing Gender-Affirming Hysterectomy. (English)
1 reference
stated in
PubMed
abstract
To evaluate operative complications and healthcare utilization in transgender patients on testosterone undergoing minimally invasive gender-affirming hysterectomy compared to control patients. (English)
source label
STUDY OBJECTIVE (English)
subsection NLM category
objective section
series ordinal
1
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
We performed a retrospective cohort study. (English)
source label
DESIGN (English)
subsection NLM category
methods section
series ordinal
2
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Operative reports were used to gather information on intraoperative complications. (English)
source label
DESIGN (English)
subsection NLM category
methods section
series ordinal
3
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
We collected information on postoperative complications, electronic medical record (EMR) messages, phone calls, emergency department utilization, and clinic visits through a 90-day postoperative period. (English)
source label
DESIGN (English)
subsection NLM category
methods section
series ordinal
4
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Healthcare utilization reasons were categorized as vaginal bleeding, pain, vaginal discharge, dysuria, urinary retention, bowel concern, incision concern, or other. (English)
source label
DESIGN (English)
subsection NLM category
methods section
series ordinal
5
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Tertiary care academic medical center. (English)
source label
SETTING (English)
subsection NLM category
methods section
series ordinal
6
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Patients aged 18 to 55 who underwent a benign minimally invasive hysterectomy with or without oophorectomy performed between January 2014 and December 2022. (English)
source label
PATIENTS (English)
subsection NLM category
methods section
series ordinal
7
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
The testosterone-using cohort consisted of patients who had a gender identity of male, transgender male, genderqueer, or nonbinary with documented testosterone use prior to surgery (n = 88). (English)
source label
PATIENTS (English)
subsection NLM category
methods section
series ordinal
8
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
The control cohort consisted of patients who identified as female, genderqueer, or nonbinary with no documented testosterone use (n = 242). (English)
source label
PATIENTS (English)
subsection NLM category
methods section
series ordinal
9
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Not applicable. (English)
source label
INTERVENTIONS (English)
subsection NLM category
methods section
series ordinal
10
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Patients using testosterone were younger, had a lower body mass index, lower American Society of Anesthesiologists class, and were more likely to be nulliparous. (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
11
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
The median time patients used testosterone was 2.5 years (1.5-5.0). (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
12
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Patients on testosterone are at increased risk of intraoperative perineal lacerations requiring repair (RR 3.3, CI 95% [1.03-10.5]). (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
13
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
A higher number of patients on testosterone reported vaginal bleeding via EMR message or phone call (RR 1.74 CI 95% [1.1-2.7]) compared to controls. (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
14
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
No difference in reasons for emergency department visits was noted. (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
15
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
The use of postoperative vaginal estrogen started at the postoperative visit was more frequent in the testosterone-using patients (7 [8.0%] vs 4 [1.7%], p = .01). (English)
source label
MEASUREMENTS AND MAIN RESULTS (English)
subsection NLM category
results section
series ordinal
16
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
This study demonstrates that testosterone use preoperatively may increase risk of intraoperative vaginal laceration requiring repair. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
17
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
Testosterone use also correlates with increased reports of vaginal bleeding through EMR message, phone call, and clinic visit. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
18
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
These results contribute new evidence to include in preoperative counseling and support existing evidence surrounding the safety of gender-affirming hysterectomy. (English)
source label
CONCLUSION (English)
subsection NLM category
conclusion section
series ordinal
19
copyright statement
Copyright © 2024 AAGL. Published by Elsevier Inc. All rights reserved. (English)
publisher
Elsevier
date copyrighted
2024
rights holder
AAGL
1 reference
stated in
PubMed
date published
October 2024
1 reference
stated in
PubMed
date issued
October 2024
1 reference
stated in
PubMed
volume
31
1 reference
stated in
PubMed
issue
10
1 reference
stated in
PubMed
page(s)
836-842
1 reference
stated in
PubMed
page start
836
1 reference
stated in
PubMed
page end
842
1 reference
stated in
PubMed
publisher item identifier
S1553-4650(24)00237-1
1 reference
stated in
PubMed
conflict-of-interest statement
Conflict of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article. (English)
series ordinal
1
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q33329&oldid=193102"